[
  {
    "title": "罗欣药业(002793.SZ)：注射用头孢西丁钠(0.5g)通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/12/27172537240895.shtml",
    "datetime": "2022-12-27 17:25:51",
    "code": "002793"
  },
  {
    "title": "罗欣药业控股股东罗欣控股合计质押1900万股 用于经营周转",
    "href": "http://stock.jrj.com.cn/2022/12/14201237213060.shtml",
    "datetime": "2022-12-14 20:12:10",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：控股股东质押1900万股",
    "href": "http://stock.jrj.com.cn/2022/12/14172137212334.shtml",
    "datetime": "2022-12-14 17:21:53",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：约1.0265亿股限售股将于12月15日解禁",
    "href": "http://stock.jrj.com.cn/2022/12/12151937205648.shtml",
    "datetime": "2022-12-12 15:19:11",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：克拉玛依珏志质押3900万股",
    "href": "http://stock.jrj.com.cn/2022/11/30215637179663.shtml",
    "datetime": "2022-11-30 21:56:41",
    "code": "002793"
  },
  {
    "title": "罗欣药业：头孢克肟胶囊获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/11/14184637137841.shtml",
    "datetime": "2022-11-14 18:46:44",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：头孢克肟胶囊获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/11/14183837137819.shtml",
    "datetime": "2022-11-14 18:38:25",
    "code": "002793"
  },
  {
    "title": "罗欣药业2022年前三季度亏损4.97亿同比由盈转亏 利息支出增加",
    "href": "http://stock.jrj.com.cn/2022/10/29115037096570.shtml",
    "datetime": "2022-10-29 11:50:45",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：第三季度净亏损3.79亿元",
    "href": "http://stock.jrj.com.cn/2022/10/28222737096030.shtml",
    "datetime": "2022-10-28 22:27:29",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：盐酸氨溴索喷雾剂新增2个规格获批",
    "href": "http://stock.jrj.com.cn/2022/09/22172837014528.shtml",
    "datetime": "2022-09-22 17:28:58",
    "code": "002793"
  },
  {
    "title": "罗欣药业：与上药控股签订战略合作伙伴框架协议",
    "href": "http://stock.jrj.com.cn/2022/09/21203537012290.shtml",
    "datetime": "2022-09-21 20:35:25",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：山东罗欣拟将所持现代物流70%股权转让给上药山东",
    "href": "http://stock.jrj.com.cn/2022/09/21202837012267.shtml",
    "datetime": "2022-09-21 20:28:05",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：与上药控股签署战略合作伙伴框架协议",
    "href": "http://stock.jrj.com.cn/2022/09/21202537012272.shtml",
    "datetime": "2022-09-21 20:25:41",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：拟放弃北京健康部分优先认缴出资权",
    "href": "http://stock.jrj.com.cn/2022/09/14200636995213.shtml",
    "datetime": "2022-09-14 20:06:28",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)上半年净亏损1.18亿元，同比转亏",
    "href": "http://stock.jrj.com.cn/2022/08/29185336948460.shtml",
    "datetime": "2022-08-29 18:53:29",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：已与全体业绩承诺方就业绩补偿事宜达成一致意见",
    "href": "http://stock.jrj.com.cn/2022/08/20155336918948.shtml",
    "datetime": "2022-08-20 15:53:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业多药品中标集采 业绩不增或反降",
    "href": "http://stock.jrj.com.cn/2022/07/21092336831272.shtml",
    "datetime": "2022-07-21 09:23:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业下属子公司中标依达拉奉注射液、注射用头孢美唑钠及注射用美罗培南3个产品",
    "href": "http://stock.jrj.com.cn/2022/07/18223136822811.shtml",
    "datetime": "2022-07-18 22:31:57",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：3项产品参与全国药品集中采购中标",
    "href": "http://stock.jrj.com.cn/2022/07/18184736822171.shtml",
    "datetime": "2022-07-18 18:47:08",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用盐酸头孢替安通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/07/15191636816942.shtml",
    "datetime": "2022-07-15 19:16:20",
    "code": "002793"
  },
  {
    "title": "罗欣药业：注射用盐酸头孢替安通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/07/15191536816922.shtml",
    "datetime": "2022-07-15 19:15:38",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)子公司奥美拉唑肠溶胶囊中标长三角(沪浙皖)联盟地区药品集中采购",
    "href": "http://stock.jrj.com.cn/2022/07/03221136777990.shtml",
    "datetime": "2022-07-03 22:11:50",
    "code": "002793"
  },
  {
    "title": "罗欣药业：参与长三角（沪浙皖）联盟地区药品集中采购中标",
    "href": "http://stock.jrj.com.cn/2022/07/03211036777951.shtml",
    "datetime": "2022-07-03 21:10:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：盐酸多奈哌齐分散片通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2022/06/27194136762352.shtml",
    "datetime": "2022-06-27 19:41:52",
    "code": "002793"
  },
  {
    "title": "罗欣药业控股股东罗欣控股合计质押2038.57万股 用于补充质押",
    "href": "http://stock.jrj.com.cn/2022/06/22201036750865.shtml",
    "datetime": "2022-06-22 20:10:51",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：控股股东质押合计2038.5666万股",
    "href": "http://stock.jrj.com.cn/2022/06/22174536750208.shtml",
    "datetime": "2022-06-22 17:45:58",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用福沙匹坦双葡甲胺获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/06/10194836720384.shtml",
    "datetime": "2022-06-10 19:48:45",
    "code": "002793"
  },
  {
    "title": "罗欣药业下属子公司中标豫晋蒙鄂湘桂琼渝贵青宁新兵团十三省(区、市、兵团)药品集中带量采购项目",
    "href": "http://stock.jrj.com.cn/2022/06/08205236713857.shtml",
    "datetime": "2022-06-08 20:52:37",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：拟回购注销3.71亿股补偿股份",
    "href": "http://stock.jrj.com.cn/2022/05/26224736682791.shtml",
    "datetime": "2022-05-26 22:47:55",
    "code": "002793"
  },
  {
    "title": "罗欣药业：拟回购注销3.71亿股补偿股份",
    "href": "http://stock.jrj.com.cn/2022/05/26192236682163.shtml",
    "datetime": "2022-05-26 19:22:55",
    "code": "002793"
  },
  {
    "title": "【龙虎榜】罗欣药业5月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/17180536655839.shtml",
    "datetime": "2022-05-17 18:05:03",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：与安翰签署消化道振动胶囊系统经销合作协议",
    "href": "http://stock.jrj.com.cn/2022/05/10143236619579.shtml",
    "datetime": "2022-05-10 14:32:36",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：2021年年度权益分派10派0.3元 股权登记日5月12日",
    "href": "http://stock.jrj.com.cn/2022/05/06193836582485.shtml",
    "datetime": "2022-05-06 19:38:43",
    "code": "002793"
  },
  {
    "title": "【龙虎榜】罗欣药业5月6日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/06180336581816.shtml",
    "datetime": "2022-05-06 18:03:13",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：拟向北京健康增资5000万元",
    "href": "http://stock.jrj.com.cn/2022/04/20164836410279.shtml",
    "datetime": "2022-04-20 16:48:59",
    "code": "002793"
  },
  {
    "title": "罗欣药业业绩未达标触发补偿条款 引入外企团队掌舵营销",
    "href": "http://stock.jrj.com.cn/2022/04/14084236330771.shtml",
    "datetime": "2022-04-14 08:42:42",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：子公司替戈拉生片1类新药获批上市",
    "href": "http://stock.jrj.com.cn/2022/04/13154636323558.shtml",
    "datetime": "2022-04-13 15:46:09",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用头孢硫脒、注射用头孢唑肟钠中标赣粤豫鄂四省联盟药品带量采购",
    "href": "http://stock.jrj.com.cn/2022/04/05162536257914.shtml",
    "datetime": "2022-04-05 16:25:23",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用谷胱甘肽继续中标福建带量采购",
    "href": "http://stock.jrj.com.cn/2022/03/30170736198285.shtml",
    "datetime": "2022-03-30 17:07:04",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：克拉玛依珏志质押3440万股",
    "href": "http://stock.jrj.com.cn/2022/03/23203634873403.shtml",
    "datetime": "2022-03-23 20:36:32",
    "code": "002793"
  },
  {
    "title": "罗欣药业控股股东一致行动人克拉玛依珏志质押3440万股 用于融资类质押",
    "href": "http://stock.jrj.com.cn/2022/03/22215134862504.shtml",
    "datetime": "2022-03-22 21:51:45",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：克拉玛依珏志解质6807.352万股",
    "href": "http://stock.jrj.com.cn/2022/03/18213034847352.shtml",
    "datetime": "2022-03-18 21:30:32",
    "code": "002793"
  },
  {
    "title": "研发投入连续三年下降 罗欣药业的创新药研发路在何方？",
    "href": "http://stock.jrj.com.cn/2022/03/07084434536522.shtml",
    "datetime": "2022-03-07 08:44:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业2021年净利4.06亿同比增长26.63% 董事长刘振腾薪酬177.15万",
    "href": "http://stock.jrj.com.cn/2022/03/04191134531059.shtml",
    "datetime": "2022-03-04 19:11:46",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：拟终止2020年股票期权与限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/03/04164534529864.shtml",
    "datetime": "2022-03-04 16:45:10",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：2021年净利增26.63%至4.06亿元 拟10派0.3元",
    "href": "http://stock.jrj.com.cn/2022/03/04164234529237.shtml",
    "datetime": "2022-03-04 16:42:23",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：拟使用不超5亿元自有资金购买银行理财产品",
    "href": "http://stock.jrj.com.cn/2022/03/04164134529062.shtml",
    "datetime": "2022-03-04 16:41:04",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：依达拉奉注射液通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2022/02/09162934313508.shtml",
    "datetime": "2022-02-09 16:29:58",
    "code": "002793"
  },
  {
    "title": "罗欣药业2021年预计净利4.5亿-5.8亿同比增长40%-80% 产品销售量回升",
    "href": "http://stock.jrj.com.cn/2022/01/21205134184249.shtml",
    "datetime": "2022-01-21 20:51:10",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：2021年度净利预增39.61%-79.94%",
    "href": "http://stock.jrj.com.cn/2022/01/21173634183279.shtml",
    "datetime": "2022-01-21 17:36:07",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用盐酸头孢吡肟通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/01/18165834170025.shtml",
    "datetime": "2022-01-18 16:58:14",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用美罗培南通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2022/01/17160634164813.shtml",
    "datetime": "2022-01-17 16:06:14",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：子公司泮托拉唑钠肠溶片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/12/24172634058593.shtml",
    "datetime": "2021-12-24 17:26:44",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：子公司头孢丙烯片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/12/24172334058583.shtml",
    "datetime": "2021-12-24 17:23:40",
    "code": "002793"
  },
  {
    "title": "罗欣药业：替格瑞洛片增加规格补充申请获批",
    "href": "http://stock.jrj.com.cn/2021/11/22160533903980.shtml",
    "datetime": "2021-11-22 16:05:56",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：子公司替格瑞洛片60mg规格获批上市",
    "href": "http://stock.jrj.com.cn/2021/11/22160533903982.shtml",
    "datetime": "2021-11-22 16:05:27",
    "code": "002793"
  },
  {
    "title": "罗欣药业：前三季度净利润4.36亿元，同比增长27.18%",
    "href": "http://stock.jrj.com.cn/2021/10/28174233770350.shtml",
    "datetime": "2021-10-28 17:42:21",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：前三季度净利升27.18%至4.36亿元",
    "href": "http://stock.jrj.com.cn/2021/10/28162733769300.shtml",
    "datetime": "2021-10-28 16:27:17",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：子公司克林霉素磷酸酯注射液获批上市",
    "href": "http://stock.jrj.com.cn/2021/10/21161733727297.shtml",
    "datetime": "2021-10-21 16:17:47",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)： 子公司盐酸纳美芬注射液获批上市",
    "href": "http://stock.jrj.com.cn/2021/10/21161533727272.shtml",
    "datetime": "2021-10-21 16:15:09",
    "code": "002793"
  },
  {
    "title": "罗欣药业2200万美元获得布地奈德溶液型鼻喷剂在大中华区独家权利",
    "href": "http://stock.jrj.com.cn/2021/10/21103433725835.shtml",
    "datetime": "2021-10-21 10:34:17",
    "code": "002793"
  },
  {
    "title": "罗欣药业：子公司与Marinomed签署许可协议 引进布地奈德溶液型鼻喷剂产品",
    "href": "http://stock.jrj.com.cn/2021/10/21100033725932.shtml",
    "datetime": "2021-10-21 10:00:12",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：引进布地奈德溶液型鼻喷剂产品大中华区独家权益",
    "href": "http://stock.jrj.com.cn/2021/10/21083633725262.shtml",
    "datetime": "2021-10-21 08:36:57",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用泮托拉唑钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/10/15172533699204.shtml",
    "datetime": "2021-10-15 17:25:52",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用头孢美唑钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/09/17182733452630.shtml",
    "datetime": "2021-09-17 18:27:54",
    "code": "002793"
  },
  {
    "title": "罗欣药业控股股东得怡恒佳质押511.21万股 用于股权类融资",
    "href": "http://stock.jrj.com.cn/2021/09/15203833441156.shtml",
    "datetime": "2021-09-15 20:38:03",
    "code": "002793"
  },
  {
    "title": "罗欣药业控股股东一致行动人得怡欣华质押356.59万股 用于股权类融资",
    "href": "http://stock.jrj.com.cn/2021/09/09200833411008.shtml",
    "datetime": "2021-09-09 20:08:05",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：左沙丁胺醇吸入溶液等5个药品获得美国FDA批准证书",
    "href": "http://stock.jrj.com.cn/2021/09/02191433375486.shtml",
    "datetime": "2021-09-02 19:14:14",
    "code": "002793"
  },
  {
    "title": "罗欣药业2021年半年度净利2.97亿元 同比净利增加38.42%",
    "href": "http://stock.jrj.com.cn/2021/08/30120133351054.shtml",
    "datetime": "2021-08-30 12:01:36",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：上半年净利增38.42%至2.97亿元",
    "href": "http://stock.jrj.com.cn/2021/08/29163333340603.shtml",
    "datetime": "2021-08-29 16:33:29",
    "code": "002793"
  },
  {
    "title": "创新产品进入收获期，董莉君女士赋能，罗欣药业（002793.SZ）前景可期",
    "href": "http://stock.jrj.com.cn/2021/08/05084733205263.shtml",
    "datetime": "2021-08-05 08:47:59",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：盐酸氨溴索喷雾剂首家获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/08/02202533190579.shtml",
    "datetime": "2021-08-02 20:25:45",
    "code": "002793"
  },
  {
    "title": "罗欣药业：聘任陈娴为公司财务负责人",
    "href": "http://stock.jrj.com.cn/2021/07/08204633102020.shtml",
    "datetime": "2021-07-08 20:46:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业聘任陈娴为公司财务负责人",
    "href": "http://stock.jrj.com.cn/2021/07/08195133065685.shtml",
    "datetime": "2021-07-08 19:51:52",
    "code": "002793"
  },
  {
    "title": "子公司未完成业绩承诺需补偿 罗欣药业合作方落标集采雪上加霜",
    "href": "http://stock.jrj.com.cn/2021/07/02073133031563.shtml",
    "datetime": "2021-07-02 07:31:55",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)2020年度权益分派10派0.5元 股权登记日为7月7日",
    "href": "http://stock.jrj.com.cn/2021/06/30164533022004.shtml",
    "datetime": "2021-06-30 16:45:43",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：替戈拉生片获准开展新适应症临床试验",
    "href": "http://stock.jrj.com.cn/2021/06/25191232997771.shtml",
    "datetime": "2021-06-25 19:12:09",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：独家引进韩国HK inno.N替戈拉生注射剂 加码P-CAB",
    "href": "http://stock.jrj.com.cn/2021/06/24171632990269.shtml",
    "datetime": "2021-06-24 17:16:15",
    "code": "002793"
  },
  {
    "title": "罗欣药业：本次集采公司下属子公司注射用艾司奥美拉唑钠及注射用兰索拉唑均中标",
    "href": "http://stock.jrj.com.cn/2021/06/24134032989091.shtml",
    "datetime": "2021-06-24 13:40:49",
    "code": "002793"
  },
  {
    "title": "罗欣药业：公司控股或参股子公司中目前暂无康复医院或康复医疗业务",
    "href": "http://stock.jrj.com.cn/2021/06/24134032989093.shtml",
    "datetime": "2021-06-24 13:40:42",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用兰索拉唑通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/06/22161832976512.shtml",
    "datetime": "2021-06-22 16:18:09",
    "code": "002793"
  },
  {
    "title": "罗欣药业：股东股份解除质押",
    "href": "http://stock.jrj.com.cn/2021/06/18180932955953.shtml",
    "datetime": "2021-06-18 18:09:26",
    "code": "002793"
  },
  {
    "title": "罗欣药业：公司控股的费县第二医院有限公司开展新生儿洗浴、新生儿抚触、无痛人流、无痛分娩等特需服务",
    "href": "http://stock.jrj.com.cn/2021/06/01102432855278.shtml",
    "datetime": "2021-06-01 10:24:24",
    "code": "002793"
  },
  {
    "title": "罗欣药业：公司将按照盈利预测补偿协议和交易所相关规则推进回购注销",
    "href": "http://stock.jrj.com.cn/2021/05/27130332828822.shtml",
    "datetime": "2021-05-27 13:03:41",
    "code": "002793"
  },
  {
    "title": "罗欣药业：公司投资建设的山东罗欣乐康制药有限公司中药产业基地工程建设项目目前已投产",
    "href": "http://stock.jrj.com.cn/2021/05/13170532748969.shtml",
    "datetime": "2021-05-13 17:05:26",
    "code": "002793"
  },
  {
    "title": "罗欣药业：业绩承诺方不存在借新冠疫情为借口逃避2020年补偿义务的情形",
    "href": "http://stock.jrj.com.cn/2021/05/13170432748973.shtml",
    "datetime": "2021-05-13 17:04:21",
    "code": "002793"
  },
  {
    "title": "罗欣药业：公司旗下所运营的费县第二人民医院目前暂无健康养老相关业务",
    "href": "http://stock.jrj.com.cn/2021/05/13170332748956.shtml",
    "datetime": "2021-05-13 17:03:56",
    "code": "002793"
  },
  {
    "title": "罗欣药业：公司投资建设的医药中间体及无菌原料药工厂已建立化学原料药、抗肿瘤原料药等生产体系",
    "href": "http://stock.jrj.com.cn/2021/05/10133032728530.shtml",
    "datetime": "2021-05-10 13:30:44",
    "code": "002793"
  },
  {
    "title": "罗欣药业：公司暂时并无获批的医美相关产品上市销售",
    "href": "http://stock.jrj.com.cn/2021/05/10130032728342.shtml",
    "datetime": "2021-05-10 13:00:16",
    "code": "002793"
  },
  {
    "title": "罗欣药业：公司目前暂未布局治疗新型冠状病毒研发产品线",
    "href": "http://stock.jrj.com.cn/2021/04/30142432486809.shtml",
    "datetime": "2021-04-30 14:24:01",
    "code": "002793"
  },
  {
    "title": "罗欣药业：公司目前生产的产品暂未通过合作伙伴为印度疫情提供纾困",
    "href": "http://stock.jrj.com.cn/2021/04/27171032463762.shtml",
    "datetime": "2021-04-27 17:10:47",
    "code": "002793"
  },
  {
    "title": "罗欣药业：公司暂时并无获批的医美相关产品上市销售",
    "href": "http://stock.jrj.com.cn/2021/04/14101532369798.shtml",
    "datetime": "2021-04-14 10:15:04",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用奥美拉唑钠通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2021/03/22162132194605.shtml",
    "datetime": "2021-03-22 16:21:40",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：替格瑞洛片获批上市",
    "href": "http://stock.jrj.com.cn/2021/02/08172031870902.shtml",
    "datetime": "2021-02-08 17:20:10",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用艾司奥美拉唑钠获批上市",
    "href": "http://stock.jrj.com.cn/2021/02/08171831870885.shtml",
    "datetime": "2021-02-08 17:18:49",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：他达拉非片获批上市",
    "href": "http://stock.jrj.com.cn/2021/02/08171731870882.shtml",
    "datetime": "2021-02-08 17:17:11",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用帕瑞昔布钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/13160831684212.shtml",
    "datetime": "2021-01-13 16:08:59",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：取得替戈拉生片1类新药上市申请受理通知书",
    "href": "http://stock.jrj.com.cn/2021/01/04151631626977.shtml",
    "datetime": "2021-01-04 15:16:30",
    "code": "002793"
  },
  {
    "title": "罗欣药业：注射用兰索拉唑通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/20185831527451.shtml",
    "datetime": "2020-12-20 18:58:31",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)：注射用兰索拉唑通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/20180631527283.shtml",
    "datetime": "2020-12-20 18:06:32",
    "code": "002793"
  },
  {
    "title": "罗欣药业控股股东罗欣控股质押1.02亿股 用于融资类质押",
    "href": "http://stock.jrj.com.cn/2020/11/27210131362900.shtml",
    "datetime": "2020-11-27 21:01:21",
    "code": "002793"
  },
  {
    "title": "罗欣药业2020年前三季度净利3.44亿下滑14.07% 新增金融机构借款",
    "href": "http://stock.jrj.com.cn/2020/10/28203631152374.shtml",
    "datetime": "2020-10-28 20:36:32",
    "code": "002793"
  },
  {
    "title": "罗欣药业子公司与韩国JW公司达成肠外营养液产品协议",
    "href": "http://stock.jrj.com.cn/2020/10/26150531133577.shtml",
    "datetime": "2020-10-26 15:05:10",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)引进韩国三腔袋肠外营养液产品",
    "href": "http://stock.jrj.com.cn/2020/10/26121731133176.shtml",
    "datetime": "2020-10-26 12:17:56",
    "code": "002793"
  },
  {
    "title": "罗欣药业2020年前三季度净利3.2亿–3.8亿同比下降 销售量有所下降",
    "href": "http://stock.jrj.com.cn/2020/10/15114231058796.shtml",
    "datetime": "2020-10-15 11:42:51",
    "code": "002793"
  },
  {
    "title": "罗欣药业：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/15081131057124.shtml",
    "datetime": "2020-10-15 08:11:47",
    "code": "002793"
  },
  {
    "title": "罗欣药业(002793.SZ)拟推3350万份股票期权与限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2020/09/07112830691764.shtml",
    "datetime": "2020-09-07 11:28:43",
    "code": "002793"
  },
  {
    "title": "罗欣药业：上半年实现营收26.80亿元 研发投入2亿元",
    "href": "http://stock.jrj.com.cn/2020/08/28090730611477.shtml",
    "datetime": "2020-08-28 09:07:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业2020年上半年净利2.15亿减少27% 疫情影响销售下降",
    "href": "http://stock.jrj.com.cn/2020/08/27213030606808.shtml",
    "datetime": "2020-08-27 21:30:52",
    "code": "002793"
  },
  {
    "title": "第三轮全国药品集采拟中选结果公布 罗欣药业两个品种中标",
    "href": "http://stock.jrj.com.cn/2020/08/24092230573138.shtml",
    "datetime": "2020-08-24 09:22:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业2020年上半年预计净利1.75亿元至2.20亿元 销售量有所下降",
    "href": "http://stock.jrj.com.cn/2020/07/15112230248212.shtml",
    "datetime": "2020-07-15 11:22:19",
    "code": "002793"
  },
  {
    "title": "罗欣药业：预计上半年净利润为1.75亿元-2.2亿元",
    "href": "http://stock.jrj.com.cn/2020/07/15091730246751.shtml",
    "datetime": "2020-07-15 09:17:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/15083030245871.shtml",
    "datetime": "2020-07-15 08:30:09",
    "code": "002793"
  },
  {
    "title": "罗欣药业聘任马家烈为公司董事会秘书",
    "href": "http://stock.jrj.com.cn/2020/07/10204830207508.shtml",
    "datetime": "2020-07-10 20:48:39",
    "code": "002793"
  },
  {
    "title": "快讯：罗欣药业急速拉升6.42% 主力资金净流入982.50万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/30130530096269.shtml",
    "datetime": "2020-06-30 13:05:01",
    "code": "002793"
  },
  {
    "title": "快讯：罗欣药业急速拉升6.42% 主力资金净流入982.50万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/30130530096270.shtml",
    "datetime": "2020-06-30 13:05:01",
    "code": "002793"
  },
  {
    "title": "P-CAB开启抑酸新篇章 罗欣药业有望切入国内百亿级抑酸药物市场",
    "href": "http://stock.jrj.com.cn/2020/06/30125830096138.shtml",
    "datetime": "2020-06-30 12:58:00",
    "code": "002793"
  },
  {
    "title": "【公告解读】罗欣药业：公司股票调入中小创新指数样本股并加入深股通名单",
    "href": "http://stock.jrj.com.cn/2020/06/17195329951162.shtml",
    "datetime": "2020-06-17 19:53:45",
    "code": "002793"
  },
  {
    "title": "东音股份变更证券简称为罗欣药业 转型进入医药制造行业",
    "href": "http://stock.jrj.com.cn/2020/05/14131129669952.shtml",
    "datetime": "2020-05-14 13:11:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业股东罗欣控股质押8700万股 用于融资类质押",
    "href": "http://stock.jrj.com.cn/2020/05/13180229662568.shtml",
    "datetime": "2020-05-13 18:02:40",
    "code": "002793"
  },
  {
    "title": "东音股份：变更证券简称为罗欣药业",
    "href": "http://stock.jrj.com.cn/2020/05/11201129643186.shtml",
    "datetime": "2020-05-11 20:11:29",
    "code": "002793"
  },
  {
    "title": "东音股份：LX-086片获药监局临床试验默示许可 目前国内尚无同类药物上市",
    "href": "http://stock.jrj.com.cn/2020/05/11164129641716.shtml",
    "datetime": "2020-05-11 16:41:24",
    "code": "002793"
  },
  {
    "title": "东音股份2020年第一季度净利1.12亿 同比下滑10.97%",
    "href": "http://stock.jrj.com.cn/2020/05/01222429441620.shtml",
    "datetime": "2020-05-01 22:24:04",
    "code": "002793"
  },
  {
    "title": "[罗欣药业]欢度五一,劳动人民最光荣",
    "href": "http://stock.jrj.com.cn/2020/04/30000030079649.shtml",
    "datetime": "2020-04-30 00:00:00",
    "code": "002793"
  },
  {
    "title": "东音股份2019年净利6.34亿较上年同期增长23.74% 消化类药品销售额同比增长",
    "href": "http://stock.jrj.com.cn/2020/04/28201129407205.shtml",
    "datetime": "2020-04-28 20:11:27",
    "code": "002793"
  },
  {
    "title": "东音股份：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/15080029292302.shtml",
    "datetime": "2020-04-15 08:00:19",
    "code": "002793"
  },
  {
    "title": "东音股份：一季度预计净利过亿 同比增长485%-588%",
    "href": "http://stock.jrj.com.cn/2020/04/14215829286635.shtml",
    "datetime": "2020-04-14 21:58:00",
    "code": "002793"
  },
  {
    "title": "东音股份：拟更名为“罗欣药业”",
    "href": "http://stock.jrj.com.cn/2020/04/07173729226550.shtml",
    "datetime": "2020-04-07 17:37:00",
    "code": "002793"
  },
  {
    "title": "东音股份股东得怡恒佳质押3068万股 用于股权类投资",
    "href": "http://stock.jrj.com.cn/2020/03/31180529159516.shtml",
    "datetime": "2020-03-31 18:05:30",
    "code": "002793"
  },
  {
    "title": "东音股份2019年净利6.34亿增长24% 经营业绩稳步增长",
    "href": "http://stock.jrj.com.cn/2020/02/26203328899454.shtml",
    "datetime": "2020-02-26 20:33:52",
    "code": "002793"
  },
  {
    "title": "东音股份：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/17022028689476.shtml",
    "datetime": "2020-01-17 02:20:00",
    "code": "002793"
  },
  {
    "title": "东音股份预计2019年盈利6.20亿元至6.50亿元 同比增长457%至484%",
    "href": "http://stock.jrj.com.cn/2020/01/16221028688965.shtml",
    "datetime": "2020-01-16 22:10:51",
    "code": "002793"
  },
  {
    "title": "东音股份2019年度净利润预增457%-484%",
    "href": "http://stock.jrj.com.cn/2020/01/16212328688770.shtml",
    "datetime": "2020-01-16 21:23:25",
    "code": "002793"
  },
  {
    "title": "东音股份：2019年度净利同比预增457%-484%",
    "href": "http://stock.jrj.com.cn/2020/01/16205628688669.shtml",
    "datetime": "2020-01-16 20:56:09",
    "code": "002793"
  },
  {
    "title": "东音股份：预计2019年净利同比增457%-484%",
    "href": "http://stock.jrj.com.cn/2020/01/16200028688438.shtml",
    "datetime": "2020-01-16 20:00:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业“借壳”东音股份上市：整体作价75.4亿元 平安系和高瓴套现有望",
    "href": "http://stock.jrj.com.cn/2020/01/02155128617675.shtml",
    "datetime": "2020-01-02 15:51:40",
    "code": "002793"
  },
  {
    "title": "12月23日14时30分A股主力资金净流入-334.75亿元，放量异动个股有凌云股份、宁波富邦、东音股份2019122303",
    "href": "http://stock.jrj.com.cn/2019/12/23143128572248.shtml",
    "datetime": "2019-12-23 14:31:22",
    "code": "002793"
  },
  {
    "title": "12月23日14时30分A股主力资金净流入-334.75亿元，放量异动个股有凌云股份、宁波富邦、东音股份",
    "href": "http://stock.jrj.com.cn/2019/12/23143028572242.shtml",
    "datetime": "2019-12-23 14:30:52",
    "code": "002793"
  },
  {
    "title": "12月23日10时A股主力资金净流入-75.12亿元，放量异动个股有惠伦晶体、福斯特、东音股份2019122302",
    "href": "http://stock.jrj.com.cn/2019/12/23105228571619.shtml",
    "datetime": "2019-12-23 10:52:01",
    "code": "002793"
  },
  {
    "title": "东音股份更换年报审计机构：由原来的瑞华变为天健",
    "href": "http://stock.jrj.com.cn/2019/12/22220928568696.shtml",
    "datetime": "2019-12-22 22:09:16",
    "code": "002793"
  },
  {
    "title": "罗欣药业借壳东音股份过会",
    "href": "http://stock.jrj.com.cn/2019/12/17211828547693.shtml",
    "datetime": "2019-12-17 21:18:23",
    "code": "002793"
  },
  {
    "title": "东音股份：重组过会 股票复牌",
    "href": "http://stock.jrj.com.cn/2019/12/17201528547514.shtml",
    "datetime": "2019-12-17 20:15:03",
    "code": "002793"
  },
  {
    "title": "东音股份重组事项获证监会有条件通过 18日起复牌",
    "href": "http://stock.jrj.com.cn/2019/12/17200228547492.shtml",
    "datetime": "2019-12-17 20:02:54",
    "code": "002793"
  },
  {
    "title": "东音股份：重组事项获有条件通过 18日复牌",
    "href": "http://stock.jrj.com.cn/2019/12/17194328547325.shtml",
    "datetime": "2019-12-17 19:43:00",
    "code": "002793"
  },
  {
    "title": "东音股份：停牌公告",
    "href": "http://stock.jrj.com.cn/2019/12/16220028542276.shtml",
    "datetime": "2019-12-16 22:00:01",
    "code": "002793"
  },
  {
    "title": "东音股份重组事项将上会 17日停牌",
    "href": "http://stock.jrj.com.cn/2019/12/16184628541315.shtml",
    "datetime": "2019-12-16 18:46:52",
    "code": "002793"
  },
  {
    "title": "证监会：东音股份、晶瑞股份重组17日上会",
    "href": "http://stock.jrj.com.cn/2019/12/11190428520762.shtml",
    "datetime": "2019-12-11 19:04:00",
    "code": "002793"
  },
  {
    "title": "东音股份前三季度盈利4679.74万 同比减少44.56%",
    "href": "http://stock.jrj.com.cn/2019/11/01083128336735.shtml",
    "datetime": "2019-11-01 08:31:58",
    "code": "002793"
  },
  {
    "title": "【东音股份】大幅拉升2.58% 股价创近2个月新高",
    "href": "http://stock.jrj.com.cn/2019/09/12102028126057.shtml",
    "datetime": "2019-09-12 10:20:46",
    "code": "002793"
  },
  {
    "title": "【东音股份】大幅拉升1.7% 股价创历史新高",
    "href": "http://stock.jrj.com.cn/2019/09/06140828100337.shtml",
    "datetime": "2019-09-06 14:08:13",
    "code": "002793"
  },
  {
    "title": "【东音股份】大幅拉升3.04% 股价创历史新高",
    "href": "http://stock.jrj.com.cn/2019/09/06110228099278.shtml",
    "datetime": "2019-09-06 11:02:33",
    "code": "002793"
  },
  {
    "title": "东音股份：上半年净利同比下滑9.72% 拟10转7",
    "href": "http://stock.jrj.com.cn/2019/08/25220128029344.shtml",
    "datetime": "2019-08-25 22:01:14",
    "code": "002793"
  },
  {
    "title": "东音股份：上半年净利同比下滑9.72% 拟10转7",
    "href": "http://stock.jrj.com.cn/2019/08/25191828028973.shtml",
    "datetime": "2019-08-25 19:18:00",
    "code": "002793"
  },
  {
    "title": "东音股份2019年上半年盈利4851万 产能稳定运行",
    "href": "http://stock.jrj.com.cn/2019/08/25175228028758.shtml",
    "datetime": "2019-08-25 17:52:03",
    "code": "002793"
  },
  {
    "title": "东音股份股东方东晖质押490万股 公司去年净利同比下滑4%",
    "href": "http://stock.jrj.com.cn/2019/07/19081727864750.shtml",
    "datetime": "2019-07-19 08:17:38",
    "code": "002793"
  },
  {
    "title": "[罗欣药业]东音科技有点蓝",
    "href": "http://stock.jrj.com.cn/2019/07/19000030079642.shtml",
    "datetime": "2019-07-19 00:00:00",
    "code": "002793"
  },
  {
    "title": "[罗欣药业]东音科技消防安全演练",
    "href": "http://stock.jrj.com.cn/2019/07/10000030079646.shtml",
    "datetime": "2019-07-10 00:00:00",
    "code": "002793"
  },
  {
    "title": "东音股份股东方东晖质押800万股 去年营收同比增长13%",
    "href": "http://stock.jrj.com.cn/2019/06/28075027767788.shtml",
    "datetime": "2019-06-28 07:50:54",
    "code": "002793"
  },
  {
    "title": "[天眼]罗欣药业一业务经理挪用公司百万资金炒股 管理漏洞险致损失200万",
    "href": "http://stock.jrj.com.cn/2019/06/21205927740184.shtml",
    "datetime": "2019-06-21 20:59:21",
    "code": "002793"
  },
  {
    "title": "罗欣药业拟借壳东音股份回归A股 称部分药物毛利率97%符合行业特点",
    "href": "http://stock.jrj.com.cn/2019/06/14162827705196.shtml",
    "datetime": "2019-06-14 16:28:26",
    "code": "002793"
  },
  {
    "title": "罗欣药业拟借壳东音股份回归A股：现金流与研发风险需关注",
    "href": "http://stock.jrj.com.cn/2019/06/06070827670040.shtml",
    "datetime": "2019-06-06 07:08:02",
    "code": "002793"
  },
  {
    "title": "东音股份重组快速推进 罗欣药业上市再进一步",
    "href": "http://stock.jrj.com.cn/2019/06/06020427669480.shtml",
    "datetime": "2019-06-06 02:04:07",
    "code": "002793"
  },
  {
    "title": "罗欣药业75亿借壳，三年近20亿净利能否兑现？",
    "href": "http://stock.jrj.com.cn/2019/05/23075727610297.shtml",
    "datetime": "2019-05-23 07:57:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业75亿借壳 三年近20亿净利能否兑现？",
    "href": "http://stock.jrj.com.cn/2019/05/23030727609588.shtml",
    "datetime": "2019-05-23 03:07:26",
    "code": "002793"
  },
  {
    "title": "罗欣药业75亿借壳回A股 回应高业绩承诺等质疑",
    "href": "http://stock.jrj.com.cn/2019/05/22194327608536.shtml",
    "datetime": "2019-05-22 19:43:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业拟借壳东音股份 释疑业绩预测合理性",
    "href": "http://stock.jrj.com.cn/2019/05/22055827604020.shtml",
    "datetime": "2019-05-22 05:58:25",
    "code": "002793"
  },
  {
    "title": "东音股份回应重大资产重组：罗欣药业“仿创结合”实力闯关A股",
    "href": "http://stock.jrj.com.cn/2019/05/22015427603704.shtml",
    "datetime": "2019-05-22 01:54:17",
    "code": "002793"
  },
  {
    "title": "投服中心参加东音股份重组说明会",
    "href": "http://stock.jrj.com.cn/2019/05/21214927603134.shtml",
    "datetime": "2019-05-21 21:49:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业揭示增长逻辑",
    "href": "http://stock.jrj.com.cn/2019/05/16151527581521.shtml",
    "datetime": "2019-05-16 15:15:11",
    "code": "002793"
  },
  {
    "title": "交易所问询东音股份重组方案 标的公司报告期净利下降引关注",
    "href": "http://stock.jrj.com.cn/invest/2019/05/10173427554883.shtml",
    "datetime": "2019-05-10 17:34:00",
    "code": "002793"
  },
  {
    "title": "交易所问询东音股份重组方案 标的公司报告期净利下降引关注",
    "href": "http://stock.jrj.com.cn/invest/2019/05/10173427571421.shtml",
    "datetime": "2019-05-10 17:34:00",
    "code": "002793"
  },
  {
    "title": "交易所问询东音股份重组方案 标的公司报告期净利下降引关注",
    "href": "http://stock.jrj.com.cn/invest/2019/05/10173427568159.shtml",
    "datetime": "2019-05-10 17:34:00",
    "code": "002793"
  },
  {
    "title": "东音股份75亿借壳标的净利润率下滑 资产负债率上升",
    "href": "http://stock.jrj.com.cn/2019/05/08075527540851.shtml",
    "datetime": "2019-05-08 07:55:55",
    "code": "002793"
  },
  {
    "title": "罗欣药业拟作价75亿元借壳 东音股份连续6日涨停",
    "href": "http://stock.jrj.com.cn/2019/05/07093327536111.shtml",
    "datetime": "2019-05-07 09:33:47",
    "code": "002793"
  },
  {
    "title": "罗欣药业拟作价75亿元借壳 东音股份连续5日涨停",
    "href": "http://stock.jrj.com.cn/2019/05/06103027528128.shtml",
    "datetime": "2019-05-06 10:30:09",
    "code": "002793"
  },
  {
    "title": "罗欣药业拟作价75亿元借壳 东音股份连续4日涨停",
    "href": "http://stock.jrj.com.cn/2019/04/30094127512132.shtml",
    "datetime": "2019-04-30 09:41:40",
    "code": "002793"
  },
  {
    "title": "75亿借壳东音股份 罗欣药业曲线回A",
    "href": "http://stock.jrj.com.cn/2019/04/30053327510409.shtml",
    "datetime": "2019-04-30 05:33:12",
    "code": "002793"
  },
  {
    "title": "罗欣药业拟作价75亿元借壳 东音股份连续3日涨停",
    "href": "http://stock.jrj.com.cn/2019/04/29100927505810.shtml",
    "datetime": "2019-04-29 10:09:24",
    "code": "002793"
  },
  {
    "title": "东音股份一季度净利1821万同比下滑10% 现金流量净额1627万元",
    "href": "http://stock.jrj.com.cn/2019/04/29064827504454.shtml",
    "datetime": "2019-04-29 06:48:54",
    "code": "002793"
  },
  {
    "title": "罗欣药业拟作价75亿元借壳 东音股份连续两日涨停",
    "href": "http://stock.jrj.com.cn/2019/04/26094527489774.shtml",
    "datetime": "2019-04-26 09:45:08",
    "code": "002793"
  },
  {
    "title": "罗欣药业拟作价75亿元借壳东音股份",
    "href": "http://stock.jrj.com.cn/2019/04/25135327481420.shtml",
    "datetime": "2019-04-25 13:53:03",
    "code": "002793"
  },
  {
    "title": "25日公司新闻聚焦：罗欣药业拟75亿借壳东音股份",
    "href": "http://stock.jrj.com.cn/2019/04/25093327479933.shtml",
    "datetime": "2019-04-25 09:33:00",
    "code": "002793"
  },
  {
    "title": "罗欣药业借壳上市预案出炉 东音股份跌停",
    "href": "http://stock.jrj.com.cn/2019/04/25092927479570.shtml",
    "datetime": "2019-04-25 09:29:17",
    "code": "002793"
  },
  {
    "title": "罗欣药业75亿借壳东音股份 三年承诺扣非净利19.5亿",
    "href": "http://stock.jrj.com.cn/2019/04/25053927477980.shtml",
    "datetime": "2019-04-25 05:39:39",
    "code": "002793"
  },
  {
    "title": "东音股份拟“腾笼换鸟” 转型医药制造业",
    "href": "http://stock.jrj.com.cn/2019/04/25040827477705.shtml",
    "datetime": "2019-04-25 04:08:27",
    "code": "002793"
  },
  {
    "title": "罗欣药业借壳东音股份上市预案出炉",
    "href": "http://stock.jrj.com.cn/2019/04/25012527477195.shtml",
    "datetime": "2019-04-25 01:25:38",
    "code": "002793"
  },
  {
    "title": "东音股份态度“大反转” 罗欣药业75亿借壳启动回A路",
    "href": "http://stock.jrj.com.cn/2019/04/24220927477338.shtml",
    "datetime": "2019-04-24 22:09:00",
    "code": "002793"
  },
  {
    "title": "东音股份：关于披露重大资产置换及发行股份购买资产预案暨上市公司相关证券复牌的提示性公告",
    "href": "http://stock.jrj.com.cn/2019/04/24212027476333.shtml",
    "datetime": "2019-04-24 21:20:00",
    "code": "002793"
  },
  {
    "title": "东音股份：罗欣药业借壳 转型医药制造业",
    "href": "http://stock.jrj.com.cn/2019/04/24184527475839.shtml",
    "datetime": "2019-04-24 18:45:00",
    "code": "002793"
  },
  {
    "title": "东音股份：罗欣药业拟逾75亿元借壳上市 25日复牌",
    "href": "http://stock.jrj.com.cn/2019/04/24183927475759.shtml",
    "datetime": "2019-04-24 18:39:13",
    "code": "002793"
  },
  {
    "title": "东音股份：罗欣药业拟逾75亿元借壳上市 明日复牌",
    "href": "http://stock.jrj.com.cn/2019/04/24182827475672.shtml",
    "datetime": "2019-04-24 18:28:08",
    "code": "002793"
  },
  {
    "title": "东音股份年报推10派3元 股权登记日4月23日",
    "href": "http://stock.jrj.com.cn/2019/04/17183327416963.shtml",
    "datetime": "2019-04-17 18:33:46",
    "code": "002793"
  },
  {
    "title": "罗欣药业有望借壳上市",
    "href": "http://stock.jrj.com.cn/2019/04/12015827369996.shtml",
    "datetime": "2019-04-12 01:58:38",
    "code": "002793"
  },
  {
    "title": "午间公告集锦：东音股份筹划收购罗欣药业",
    "href": "http://stock.jrj.com.cn/2019/04/11121527366237.shtml",
    "datetime": "2019-04-11 12:15:35",
    "code": "002793"
  },
  {
    "title": "午间公告：东音股份筹划收购罗欣药业；模塑科技一季度业绩大幅预增",
    "href": "http://stock.jrj.com.cn/2019/04/11121327366256.shtml",
    "datetime": "2019-04-11 12:13:00",
    "code": "002793"
  },
  {
    "title": "交易提示：东音股份、刚泰控股、博威合金临时停牌",
    "href": "http://stock.jrj.com.cn/2019/04/11091027365279.shtml",
    "datetime": "2019-04-11 09:10:00",
    "code": "002793"
  },
  {
    "title": "东音股份：关于部分首次公开发行前已发行股份上市流通的提示性公告",
    "href": "http://stock.jrj.com.cn/2019/04/10210027362871.shtml",
    "datetime": "2019-04-10 21:00:03",
    "code": "002793"
  },
  {
    "title": "东音股份：公司厂区发生火灾事故",
    "href": "http://stock.jrj.com.cn/2019/04/09191627355613.shtml",
    "datetime": "2019-04-09 19:16:27",
    "code": "002793"
  },
  {
    "title": "东音股份：公司发生火灾事故 未对生产经营造成实质影响",
    "href": "http://stock.jrj.com.cn/2019/04/09191527355612.shtml",
    "datetime": "2019-04-09 19:15:48",
    "code": "002793"
  },
  {
    "title": "东音股份：实控人一致行动人减持公司可转债",
    "href": "http://stock.jrj.com.cn/2019/03/26173827242502.shtml",
    "datetime": "2019-03-26 17:38:00",
    "code": "002793"
  },
  {
    "title": "[罗欣药业]东音科技荣获“三八”大溪镇非公企业女职工登山比赛”团体第一名",
    "href": "http://stock.jrj.com.cn/2019/03/07000030079648.shtml",
    "datetime": "2019-03-07 00:00:00",
    "code": "002793"
  },
  {
    "title": "东音股份去年净利1亿元下滑3.9% 董事长年薪48万元",
    "href": "http://stock.jrj.com.cn/2019/02/26232627093871.shtml",
    "datetime": "2019-02-26 23:26:30",
    "code": "002793"
  },
  {
    "title": "东音股份：2018年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2019/02/25212027085862.shtml",
    "datetime": "2019-02-25 21:20:02",
    "code": "002793"
  },
  {
    "title": "东音股份向下修正“东音转债”转股价格",
    "href": "http://stock.jrj.com.cn/2018/11/20190225380804.shtml",
    "datetime": "2018-11-20 19:02:52",
    "code": "002793"
  },
  {
    "title": "东音股份：向下修正“东音转债”转股价格",
    "href": "http://stock.jrj.com.cn/2018/11/20184725380651.shtml",
    "datetime": "2018-11-20 18:47:00",
    "code": "002793"
  },
  {
    "title": "东音股份：董事会提议向下修正可转债转股价格",
    "href": "http://stock.jrj.com.cn/2018/11/04170325301296.shtml",
    "datetime": "2018-11-04 17:03:00",
    "code": "002793"
  },
  {
    "title": "东音股份：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/23202025247763.shtml",
    "datetime": "2018-10-23 20:20:00",
    "code": "002793"
  },
  {
    "title": "东音股份：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/21203024982650.shtml",
    "datetime": "2018-08-21 20:30:00",
    "code": "002793"
  },
  {
    "title": "东音股份：对外投资设立控股子公司",
    "href": "http://stock.jrj.com.cn/2018/08/08210224926003.shtml",
    "datetime": "2018-08-08 21:02:24",
    "code": "002793"
  },
  {
    "title": "东音股份可转债中签号码出炉 共9.171万个",
    "href": "http://stock.jrj.com.cn/2018/08/05161524905929.shtml",
    "datetime": "2018-08-05 16:15:00",
    "code": "002793"
  },
  {
    "title": "东音股份：控股股东及部分董事完成股份增持计划",
    "href": "http://stock.jrj.com.cn/2018/08/02185624896901.shtml",
    "datetime": "2018-08-02 18:56:27",
    "code": "002793"
  },
  {
    "title": "东音股份深度报告：地下水的搬运工",
    "href": "http://stock.jrj.com.cn/2018/05/17100724552301.shtml",
    "datetime": "2018-05-17 10:07:00",
    "code": "002793"
  },
  {
    "title": "东音股份：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/24203024442678.shtml",
    "datetime": "2018-04-24 20:30:00",
    "code": "002793"
  },
  {
    "title": "东音股份：2017年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2018/03/05203024194400.shtml",
    "datetime": "2018-03-05 20:30:00",
    "code": "002793"
  },
  {
    "title": "东音股份2016年净利同比增长22.71％ 拟10派6元",
    "href": "http://stock.jrj.com.cn/2017/03/19173922196557.shtml",
    "datetime": "2017-03-19 17:39:11",
    "code": "002793"
  },
  {
    "title": "过往业绩增长不稳定 东音股份高送转遭问询",
    "href": "http://stock.jrj.com.cn/2016/11/28230321764615.shtml",
    "datetime": "2016-11-28 23:03:49",
    "code": "002793"
  },
  {
    "title": "东音股份：高送转预案在可供分配范围之内",
    "href": "http://stock.jrj.com.cn/2016/11/28161721762933.shtml",
    "datetime": "2016-11-28 16:17:10",
    "code": "002793"
  },
  {
    "title": "东音股份：股价不排除利好兑现后出现调整",
    "href": "http://stock.jrj.com.cn/2016/11/24070521747545.shtml",
    "datetime": "2016-11-24 07:05:59",
    "code": "002793"
  },
  {
    "title": "东音股份年报推高送转 拟10转10派6元",
    "href": "http://stock.jrj.com.cn/2016/11/23165221745771.shtml",
    "datetime": "2016-11-23 16:52:27",
    "code": "002793"
  },
  {
    "title": "东音股份公开发行2500万股将于4月15日上市交易",
    "href": "http://stock.jrj.com.cn/ipo/2016/04/13205320824746.shtml",
    "datetime": "2016-04-13 20:53:30",
    "code": "002793"
  },
  {
    "title": "东音股份逾11万股遭弃购 使用中签查询神器防弃购",
    "href": "http://stock.jrj.com.cn/2016/04/11221620813085.shtml",
    "datetime": "2016-04-11 22:16:35",
    "code": "002793"
  },
  {
    "title": "东音股份4月6日申购宝典 顶格申购获配20签",
    "href": "http://stock.jrj.com.cn/ipo/2016/04/05133120784482.shtml",
    "datetime": "2016-04-05 13:31:00",
    "code": "002793"
  }
]